Caricamento...
Glucose and lipid-related biomarkers and the antidepressant response to infliximab in patients with treatment-resistant depression
The tumor necrosis factor (TNF) antagonist infliximab was previously found to reduce depressive symptoms in patients with treatment-resistant major depression (TRD) who exhibited high baseline inflammation, as reflected by plasma C-reactive protein (CRP) >5mg/L. Further predictors of antidepressa...
Salvato in:
| Pubblicato in: | Psychoneuroendocrinology |
|---|---|
| Autori principali: | , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6214671/ https://ncbi.nlm.nih.gov/pubmed/30249443 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.psyneuen.2018.09.004 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|